US4291022A
(en)
|
1975-03-11 |
1981-09-22 |
Sandoz Ltd. |
Organic compounds
|
US4133782A
(en)
|
1976-06-07 |
1979-01-09 |
The Salk Institute For Biological Studies |
Somatostatin analogs with dissociated biological activities
|
US4190575A
(en)
|
1977-12-27 |
1980-02-26 |
American Home Products Corporation |
Polypeptides related to somatostatin
|
DE2860734D1
(en)
|
1977-06-08 |
1981-09-03 |
Merck & Co Inc |
Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
|
US4211693A
(en)
|
1977-09-20 |
1980-07-08 |
The Salk Institute For Biological Studies |
Peptides with para-substituted phenylalanine
|
LU78191A1
(de)
|
1977-09-28 |
1979-05-25 |
Ciba Geigy Ag |
Verfahren zur herstellung von neuen cyclopeptiden
|
JPS5819669B2
(ja)
|
1978-10-28 |
1983-04-19 |
白井松新薬株式会社 |
新規生理活性ペプチド化合物及びその製造法
|
US4190648A
(en)
|
1979-03-13 |
1980-02-26 |
Merck & Co., Inc. |
Peptides having somatostatin activity
|
US4316890A
(en)
|
1979-03-16 |
1982-02-23 |
Ciba-Geigy Corporation |
Peptides and processes for the manufacture thereof
|
US4328214A
(en)
|
1979-07-04 |
1982-05-04 |
Ciba-Geigy Corporation |
Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
|
US4310518A
(en)
|
1979-10-31 |
1982-01-12 |
Merck & Co., Inc. |
Cyclic hexapeptide somatostatin analogs
|
US4235886A
(en)
|
1979-10-31 |
1980-11-25 |
Merck & Co., Inc. |
Cyclic hexapeptide somatostatin analogs
|
US4369179A
(en)
|
1979-12-14 |
1983-01-18 |
Ciba-Geigy Corporation |
Acylpeptides
|
US4282143A
(en)
|
1980-06-13 |
1981-08-04 |
American Home Products Corporation |
Octapeptides lowering growth hormone
|
US4360516A
(en)
|
1981-04-13 |
1982-11-23 |
Merck & Co., Inc. |
Modified D-retro cyclic hexapeptide somatostatin analogs
|
ATE14226T1
(de)
|
1981-12-24 |
1985-07-15 |
Ciba Geigy Ag |
Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
|
FR2522655B1
(fr)
|
1982-03-05 |
1987-03-06 |
Sanofi Sa |
Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
|
US4522813A
(en)
|
1983-10-27 |
1985-06-11 |
Merck & Co., Inc. |
Cyclic hexapeptide somatostatin analogs
|
US4659693A
(en)
|
1984-04-30 |
1987-04-21 |
Syntex (U.S.A.) Inc. |
N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides
|
US4632979A
(en)
|
1984-06-18 |
1986-12-30 |
Tulane Educational Fund |
Therapeutic LHRH analogs
|
US4684620A
(en)
|
1984-09-04 |
1987-08-04 |
Gibson-Stephens Neuropharmaceuticals, Inc. |
Cyclic polypeptides having mu-receptor specificity
|
US5003011A
(en)
|
1985-04-09 |
1991-03-26 |
The Administrators Of The Tulane Educational Fund |
Therapeutic decapeptides
|
US4650787A
(en)
|
1985-04-25 |
1987-03-17 |
Schally Andrew Victor |
Biologically active octapeptides
|
US4725577A
(en)
|
1985-04-25 |
1988-02-16 |
Administrators Of The Tulane Educational Fund |
Biologically active lysine containing octapeptides
|
US4585755A
(en)
|
1985-04-29 |
1986-04-29 |
Merck & Co., Inc. |
Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
|
US4904642A
(en)
|
1985-09-12 |
1990-02-27 |
The Administrators Of The Tulane Educational Fund |
Therapeutic somatostatin analogs
|
US4853371A
(en)
|
1986-06-17 |
1989-08-01 |
The Administrators Of The Tulane Educational Fund |
Therapeutic somatostatin analogs
|
US4803261A
(en)
|
1986-06-27 |
1989-02-07 |
The Administrators Of The Tulane Educational Fund |
Method for synthesizing a peptide containing a non-peptide
|
NL194729C
(nl)
|
1986-10-13 |
2003-01-07 |
Novartis Ag |
Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
|
US4871717A
(en)
|
1987-01-07 |
1989-10-03 |
Administrators Of The Tulane Educational Fund |
Peptides
|
JP2795449B2
(ja)
|
1987-09-24 |
1998-09-10 |
ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド |
治療用ペプチド
|
US5084555A
(en)
|
1989-08-21 |
1992-01-28 |
The Administrators Of The Tulane Educational Fund |
An octapeptide bombesin analog
|
AU632468B2
(en)
|
1988-02-01 |
1993-01-07 |
Upjohn Company, The |
Renin inhibiting peptides with polar end groups
|
ZA895838B
(en)
|
1988-08-18 |
1991-03-27 |
Syntex Inc |
Pharmaceutical compounds
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
HU208439B
(en)
|
1988-10-14 |
1993-10-28 |
Univ Tulane |
Process for producing pharmaceutical peptides
|
US5171835A
(en)
|
1988-10-21 |
1992-12-15 |
The Administrators Of The Tulane Educational Fund |
LHRH antagonists
|
CA2012115C
(en)
|
1989-03-15 |
2001-07-03 |
Biomeasure, Inc. |
Iodinated somatostatins
|
CA2053250A1
(en)
|
1989-04-26 |
1990-10-27 |
David H. Coy |
Linear somatostatin analogs
|
WO1991009056A1
(en)
|
1989-12-08 |
1991-06-27 |
The Administrators Of The Tulane Educational Fund |
Octapeptide analogs of somatostatin having threonine at the sixth position
|
DK0450461T3
(da)
|
1990-04-06 |
1995-10-23 |
Univ Tulane |
LHRH-analoger
|
EP0527914A4
(en)
|
1990-05-04 |
1993-08-11 |
The Administrators Of The Tulane University Educational Fund |
Novel synthetic grf analogs
|
HUT62604A
(en)
|
1990-05-09 |
1993-05-28 |
Univ Tulane |
Process for producing peptides for treating tissue proliferation and pharmaceutical compositions comprising same
|
IT1240643B
(it)
|
1990-05-11 |
1993-12-17 |
Mediolanum Farmaceutici Spa |
Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
|
IL99552A0
(en)
|
1990-09-28 |
1992-08-18 |
Ixsys Inc |
Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
|
HU207104B
(en)
|
1991-01-25 |
1993-03-01 |
Biosignal Kutato Fejlesztoe Kf |
Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
|
US6083915A
(en)
|
1991-05-10 |
2000-07-04 |
Biomeasure, Inc. |
Method for treating liver cancer
|
US5240561A
(en)
|
1992-02-10 |
1993-08-31 |
Industrial Progress, Inc. |
Acid-to-alkaline papermaking process
|
AU3658093A
(en)
|
1992-02-10 |
1993-09-03 |
Seragen, Inc. |
Desensitization to specific allergens
|
US5656727A
(en)
|
1992-09-15 |
1997-08-12 |
The Administrators Of The Tulane Educational Fund |
Antagonists of LHRH
|
WO1994011397A1
(en)
|
1992-11-13 |
1994-05-26 |
The Administrators Of The Tulane Educational Fund |
Ghrh agonists
|
AU5668894A
(en)
|
1992-11-13 |
1994-06-08 |
The Administrators Of The Tulane Eductional Fund |
Ghrh agonists
|
GB9305735D0
(en)
|
1993-03-19 |
1993-05-05 |
North John R |
Novel agent for controlling cell activity
|
SK15096A3
(en)
|
1993-08-09 |
1996-07-03 |
Biomeasure Inc |
Therapeutic peptide derivatives and a method of their application
|
US5550212A
(en)
|
1993-12-17 |
1996-08-27 |
The Administrators Of The Tulane Educational Fund |
Analogues of hGH-RH(1-29)NH2 having antagonistic activity
|
AUPM985694A0
(en)
|
1994-12-02 |
1995-01-05 |
Farmer, Mostyn |
Golf training aid
|
US5792747A
(en)
|
1995-01-24 |
1998-08-11 |
The Administrators Of The Tulane Educational Fund |
Highly potent agonists of growth hormone releasing hormone
|
ES2124496T3
(es)
|
1995-03-13 |
1999-02-01 |
Biomeasure Inc |
Analogos de bombesina.
|
EP0820296A4
(en)
|
1995-04-14 |
1999-06-30 |
Univ Tulane |
ANALOGS OF THE GROWTH HORMONE-RELEASING FACTOR
|
GB9508204D0
(en)
*
|
1995-04-21 |
1995-06-07 |
Speywood Lab Ltd |
A novel agent able to modify peripheral afferent function
|
MY147327A
(en)
|
1995-06-29 |
2012-11-30 |
Novartis Ag |
Somatostatin peptides
|
US5942489A
(en)
|
1996-05-03 |
1999-08-24 |
The Administrators Of The Tulane Educational Fund |
HGH-RH(1-29)NH2 analogues having antagonistic activity
|
GB9617671D0
(en)
*
|
1996-08-23 |
1996-10-02 |
Microbiological Res Authority |
Recombinant toxin fragments
|
AU3215597A
(en)
|
1996-08-30 |
1998-03-19 |
Biomeasure Incorporated |
Method of inhibiting fibrosis with a somatostatin agonist
|
US5968903A
(en)
|
1998-05-07 |
1999-10-19 |
Biomeasure, Incorporated |
Inhibition of H. pylori proliferation
|
RU2214420C2
(ru)
|
1998-05-13 |
2003-10-20 |
Биотекон Гезелльшафт Фюр Биотехнологише Энтвиклунг Унд Консультинг Мбх |
Гибридный белок для ингибирования дегрануляции мастоцитов и его применение
|
DK1098664T3
(da)
|
1998-07-22 |
2003-11-17 |
Osprey Pharmaceuticals Ltd |
Sammensætninger og deres anvendelser til at behandle sekundær vævsskade og andre inflammatoriske tilstande og forstyrrelser
|
NZ509348A
(en)
|
1998-07-30 |
2004-02-27 |
Sod Conseils Rech Applic |
Use of a somatostatin analogue Lanreotide
|
US20040071736A1
(en)
*
|
1998-08-25 |
2004-04-15 |
Health Protection Agency |
Methods and compounds for the treatment of mucus hypersecretion
|
GB9818548D0
(en)
|
1998-08-25 |
1998-10-21 |
Microbiological Res Authority |
Treatment of mucas hypersecretion
|
US6057422A
(en)
|
1998-11-25 |
2000-05-02 |
The Administrators Of The Tulane Educational Fund |
Antagonistic analogs of GH-RH inhibiting IGF-I and -II
|
US6776990B2
(en)
|
1999-04-08 |
2004-08-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pancreatitis
|
US6358697B2
(en)
|
1999-04-21 |
2002-03-19 |
Children's Hospital Medical Center |
Intracellular pharmaceutical targeting
|
AR020862A1
(es)
|
1999-06-04 |
2002-05-29 |
Sod Conseils Rech Applic |
Neuromedina b y agonistas del receptor de somatostatina
|
ES2277854T5
(es)
*
|
1999-08-25 |
2011-02-04 |
Allergan, Inc. |
Neurotoxinas recombinantes activables.
|
US20080032931A1
(en)
*
|
1999-08-25 |
2008-02-07 |
Steward Lance E |
Activatable clostridial toxins
|
US20030180289A1
(en)
*
|
1999-09-23 |
2003-09-25 |
Foster Keith Alan |
Inhibition of secretion from non-neuronal cells
|
GB9922554D0
(en)
|
1999-09-23 |
1999-11-24 |
Microbiological Res Authority |
Inhibition of secretion from non-neuronal cells
|
US7838008B2
(en)
*
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating diverse cancers
|
US6831059B2
(en)
*
|
2000-10-20 |
2004-12-14 |
Allergan, Inc. |
Compositions and methods for treating gonadotrophin related illnesses
|
US6827931B1
(en)
*
|
2000-10-20 |
2004-12-07 |
Allergan, Inc. |
Method for treating endocrine disorders
|
WO2004076634A2
(en)
*
|
2003-02-24 |
2004-09-10 |
Ira Sanders |
Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
|
TW200517400A
(en)
*
|
2003-08-05 |
2005-06-01 |
Univ Tulane |
Antagonistic analogs of GH-RH (2003)
|
US7514088B2
(en)
*
|
2005-03-15 |
2009-04-07 |
Allergan, Inc. |
Multivalent Clostridial toxin derivatives and methods of their use
|
AU2005279741B2
(en)
*
|
2004-09-01 |
2011-10-06 |
Allergan, Inc. |
Degradable clostridial toxins
|
GB0426394D0
(en)
*
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
WO2006059093A2
(en)
*
|
2004-12-01 |
2006-06-08 |
Health Protection Agency |
Fusion proteins
|
US8399400B2
(en)
*
|
2004-12-01 |
2013-03-19 |
Syntaxin, Ltd. |
Fusion proteins
|
GB0426397D0
(en)
*
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
CA2601577A1
(en)
*
|
2005-03-15 |
2006-09-21 |
Allergan, Inc. |
Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
|
ES2369558T3
(es)
|
2005-09-19 |
2011-12-01 |
Allergan, Inc. |
Toxinas clostridiales y toxinas clostridiales activables.
|
EP1834962A1
(de)
|
2006-03-15 |
2007-09-19 |
Biotecon Therapeutics GmbH |
PEGyliertes mutiertes Clostridium botulinum Toxin
|
EP2038299A2
(en)
|
2006-07-11 |
2009-03-25 |
Allergan, Inc. |
Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for non-clostridial toxin target cells
|
CA2658260A1
(en)
*
|
2006-07-11 |
2008-01-17 |
Allergan, Inc. |
Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells
|
JP5799397B2
(ja)
*
|
2008-06-12 |
2015-10-28 |
イプセン・バイオイノベーション・リミテッドIpsen Bioinnovation Limited |
癌の抑制
|
US20110171191A1
(en)
*
|
2008-06-12 |
2011-07-14 |
Syntaxin Limited |
Suppression of neuroendocrine diseases
|
US10057187B1
(en)
|
2015-05-27 |
2018-08-21 |
Amazon Technologies, Inc. |
Dynamic resource creation to connect client resources in a distributed system
|